24.86
price up icon0.24%   0.06
after-market Handel nachbörslich: 24.87 0.01 +0.04%
loading

Finanzdaten der Pfizer Inc-Aktie (PFE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.42%
14,879.00
14,249.00 13,232.00 12,734.00 18,282.00
Cost Of Revenue
55.32%
3,379.00
7,563.00 9,269.00 3,237.00 4,886.00
Gross Profit
72.00%
11,500.00
6,686.00 3,963.00 9,497.00 13,396.00
Operating Expenses
25.30%
8,079.00
10,815.00 7,315.00 7,228.00 7,126.00
Interest Income/Expense
14.83%
790.00
688.00 695.00 508.00 318.00
Benefits Costs and Expenses
37.65%
11,458.00
18,378.00 16,584.00 10,465.00 12,012.00
Costs And Expenses
37.65%
11,458.00
18,378.00 16,584.00 10,465.00 12,012.00
Operating Income/Loss
182.85%
3,421.00
-4,129.00 -3,352.00 2,269.00 6,270.00
Income/Loss From Continuing Operations Before Tax
182.85%
3,421.00
-4,129.00 -3,352.00 2,269.00 6,270.00
Income Tax Expense/Benefit, Deferred
76.26%
-441.00
-1,858.00 -113.00 -873.00 -598.00
Income Tax Expense/Benefit
136.86%
293.00
-795.00 -964.00 -71.00 715.00
Income/Loss From Continuing Operations After Tax
193.79%
3,128.00
-3,335.00 -2,388.00 2,340.00 5,555.00
Income/Loss From Discontinued Operations, Net Of Tax
80.77%
-5.00
-26.00 12.00 -2.00 1.00
Net Income/Loss
192.95%
3,123.00
-3,360.00 -2,376.00 2,338.00 5,556.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
11.11%
8.00
9.00 6.00 11.00 13.00
Basic Average Shares
565.60K%
5,657.00
1.00 5,646.00 5,646.00 5,634.00
Diluted Average Shares
114.04K%
5,697.00
-5.00 5,646.00 5,713.00 5,727.00
Basic Earnings Per Share
193.22%
0.55
-0.59 -0.42 0.41 0.98
Diluted Earnings Per Share
193.22%
0.55
-0.59 -0.42 0.41 0.97
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$278.76
price down icon 1.71%
drug_manufacturers_general SNY
$48.51
price up icon 1.13%
drug_manufacturers_general BMY
$56.80
price up icon 1.03%
drug_manufacturers_general NVS
$103.04
price down icon 0.02%
drug_manufacturers_general MRK
$96.56
price up icon 0.26%
Kapitalisierung:     |  Volumen (24h):